Clinical Trial Update: Squalamine Lactate Eye Drops in Combination With Ranibizumab in Patients With Diabetic Macular Edema (DME) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Squalamine lactate eye drops with ranibizumab for diabetic macular edema has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema
• Diabetic Retinopathy

Drugs mentioned

• Lucentis (ranibizumab)
• Squalamine lactate eye drops (squalamine lactate)

Snippet

Sponsor: Starr Muscle | Conditions: Diabetic Retinopathy | Phase 2 | Status: WITHDRAWN